Literature DB >> 8094397

Immunoglobulin G subclass responses against the structural components of Puumala virus.

A Lundkvist1, S Björsten, B Niklasson.   

Abstract

Sera from sequentially bled nephropathia epidemica patients (acute-phase, convalescent-phase, and 2-year sera) and sera from 10 to 20 years postinfection were examined by immunoglobulin G (IgG) subclass-specific ELISAs for reactivities against each of the Puumala virus structural proteins (N, G1, and G2). IgG1 was found to be the dominating antiviral subclass, and most of the patients had IgG1 directed to all three structural proteins at all times with a continuous increase over time. IgG2 to the three viral proteins was detected in very low amounts in only a few of the samples. All of the serially bled patients developed IgG3 against each of the proteins, but the responses against the different viral components varied; anti-N- and anti-G1-specific IgG3 showed a peak in the convalescent-phase samples, while the anti-G2 IgG3 response was highest in the acute-phase sera. Eight of ten serially bled patients developed specific IgG4. The IgG4 responses showed similar patterns against all three viral proteins with very low optical density values in the acute- and convalescent-phase samples, followed by higher optical densities in the sera drawn 2 years after infection. Seven of nine 10-year sera contained virus-specific IgG4. These results support the theory concerning the persistence of Puumala virus or viral antigens several years after infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094397      PMCID: PMC262767          DOI: 10.1128/jcm.31.2.368-372.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Antibody isotype response after human cytomegalovirus infection.

Authors:  A M van Loon; F W Heessen; J T van der Logt
Journal:  J Virol Methods       Date:  1987-02       Impact factor: 2.014

2.  IgG subclasses in viral infections.

Authors:  F Skvaril
Journal:  Monogr Allergy       Date:  1986

3.  Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults.

Authors:  D K Wagner; D L Nelson; E E Walsh; C B Reimer; F W Henderson; B R Murphy
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Isolation of the nephropathia epidemica agent in Sweden.

Authors:  B Niklasson; J Le Duc
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

5.  Propagation of nephropathia epidemica virus in cell culture.

Authors:  R Yanagihara; D Goldgaber; P W Lee; H L Amyx; D C Gajdusek; C J Gibbs; A Svedmyr
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

6.  Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica.

Authors:  M Brummer-Korvenkontio; H Henttonen; A Vaheri
Journal:  Scand J Infect Dis Suppl       Date:  1982

7.  Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.

Authors:  V A Sundqvist; A Linde; B Wahren
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

8.  Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome.

Authors:  C S Schmaljohn; S E Hasty; J M Dalrymple; J W LeDuc; H W Lee; C H von Bonsdorff; M Brummer-Korvenkontio; A Vaheri; T F Tsai; H L Regnery
Journal:  Science       Date:  1985-03-01       Impact factor: 47.728

9.  Antibodies to Puumala virus in humans determined by neutralization test.

Authors:  J Hörling; A Lundkvist; J W Huggins; B Niklasson
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

10.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

View more
  6 in total

1.  Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis.

Authors:  B Hjelle; S Jenison; N Torrez-Martinez; B Herring; S Quan; A Polito; S Pichuantes; T Yamada; C Morris; F Elgh; H W Lee; H Artsob; R Dinello
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica).

Authors:  K B Sjölander; F Elgh; H Kallio-Kokko; O Vapalahti; M Hägglund; V Palmcrantz; P Juto; A Vaheri; B Niklasson; A Lundkvist
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Detection and subsequent sequencing of Puumala virus from human specimens by PCR.

Authors:  J Hörling; A Lundkvist; K Persson; M Mullaart; T Dzagurova; A Dekonenko; E Tkachenko; B Niklasson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans.

Authors:  A Lundkvist; S Björsten; B Niklasson; N Ahlborg
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 5.  Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture.

Authors:  Hong Jiang; Hong Du; Li M Wang; Ping Z Wang; Xue F Bai
Journal:  Front Cell Infect Microbiol       Date:  2016-02-03       Impact factor: 5.293

6.  Long-lived memory T lymphocyte responses after hantavirus infection.

Authors:  Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.